Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 Pneumonia: A Randomized,Open-label,Controlled Clinical Trial

NCT04405921 is registered in ClinicalTrials.gov with Centre Hôpital Universitaire Farhat Hached as lead sponsor.

NCT NCT04405921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04405921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 Pneumonia: A Randomized,Open-label,Controlled Clinical Trial
Lead sponsor
Centre Hôpital Universitaire Farhat Hached
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2020
Completion date
March 31, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 pneumonia